Antiviral Therapy in HCV-Infected Decompensated Cirrhotics

QR Code

Antiviral Therapy in HCV-Infected Decompensated Cirrhotics

None

Saved in:

Bibliographic Details
Main Author:	Danish, Fazal-I-Akbar
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/31797
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Potentials of antiviral therapy at patients with liver cirrhosis in an outcome of HCV-infection
by: E. N. Bessonova
Published: (2011-06-01)

Flaviviral Infections and Potential Targets for Antiviral Therapy
by: Baier, Andrea
Published: (2011)

Interleukin 28B polymorphism impact on early HCV kinetics in HCV-infected liver transplant recipients undergoing antiviral therapy
by: V. E. Syutkin, et al.
Published: (2011-12-01)

Management of Recurrent HCV and HBV Infections after Liver Transplantation
by: Wawrzynowicz-Syczewska, Marta
Published: (2012)

Experience of effective antiviral therapy in a liver recipient with recurrent HCV infection genotype 1
by: D. V. Umrik, et al.
Published: (2019-01-01)

HBV & HCV Immunopathogenesis
by: Lokhande, Megha U., et al.
Published: (2011)

HCV-Recurrence After Liver Transplantation
by: Eurich, Dennis, et al.
Published: (2012)

Changes of Peripheral Blood Cells in Patients with Cirrhotic Portal Hypertension
by: Yunfu, Lv
Published: (2012)

The Role of Correcting Structural and Functional Albumin Properties in Ascites Control in Decompensated Cirrhotic Patients
by: A. A. Turkina, et al.
Published: (2023-09-01)

EVALUATION OF EFFECTIVENESS OF ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C, CAUSED BY HCV GENOTYPE 6
by: D. A. Lioznov, et al.
Published: (2017-04-01)

Virus Diagnostics and Antiviral Therapy in Acute Retinal Necrosis (ARN)
by: Rautenberg, Peter, et al.
Published: (2012)

The Bacterial Endotoxins Levels in the Blood of Cirrhotic Patients as Predictor of the Risk of Esophageal Varices Bleeding
by: Garbuzenko, Dmitry, et al.
Published: (2012)

HCV and Drug Use – What Can Be Learned from the Failure to Control This Epidemic?
by: Chossegros, Philippe
Published: (2012)

Real-world effectiveness and safety of pan-genotypic antiviral therapy for chronic HCV-infection: data from three clinical centers in St. Petersburg
by: D. A. Gusev, et al.
Published: (2023-01-01)

Impact of HCV eradication by directly acting antivirals on glycemic indices in chronic hepatitis C patients -a nationwide Taiwan HCV registry
by: Tyng-Yuan Jang, et al.
Published: (2025-08-01)

Cirrhotic cardiomyopathy
by: S. N. Mammayev, et al.
Published: (2010-06-01)

EXTRA LIVER MANIFESTATION WITH HCV-INFECTION
by: U. K. Axmadaliyeva, et al.
Published: (2019-06-01)

Analysis of mortality and risk of death in HCV- and HCV/HIV-infected patients with extrahepatic manifestations
by: N. V. Dunaeva, et al.
Published: (2022-07-01)

Characteristics of HCV infection in oncohematological patients
by: D. A. Lioznov, et al.
Published: (2020-03-01)

Elimination of hcv-infection: a history with continuation
by: K. V. Zhdanov, et al.
Published: (2018-12-01)

Targeting Norovirus: Strategies for the Discovery of New Antiviral Drugs
by: Rocha-Pereira, Joana, et al.
Published: (2012)

Long-term efficacy of entecavir antiviral therapy and its role in fibrosis reversal among patients with decompensated liver cirrhosis
by: Ping Lu, et al.
Published: (2025-08-01)

PREVALENCE AND FACTORS ASSOCIATED WITH BACTERIAL INFECTION IN CIRRHOTIC PATIENTS IN TOGO
by: Laté Mawuli LAWSON-ANANISSOH, et al.
Published: (2025-07-01)

Antiviral Activity of Lactoferrin and Ovotransferrin Derived Peptides Towards Herpesviridae
by: Giansanti, Francesco, et al.
Published: (2012)

Detection rate of specific antibodies to the HCV CORE+1 protein in “naive” cronically HCV-infected patients in depends on the stage of liver fibrosis and the HCV subtype
by: E. V. Lichnaya, et al.
Published: (2021-01-01)

Diagnostics, management and treatment of HCV-infection (Part 1)
by: article Editorial
Published: (2010-02-01)

Diagnostics, management and treatment of HCV-infection (Part 2)
by: article Editorial
Published: (2010-04-01)

Discovery of Novel Antiviral Agents Directed Against the Influenza A Virus Nucleoprotein
by: Aida, Yoko, et al.
Published: (2012)

T Cell Suppression in Burn and Septic Injuries
by: Fazal, Nadeem
Published: (2012)

Chemokine Responses to Hepatitis C Virus and Their Impact in Mediating the Treatment Responses of Antiviral Treatment
by: Florholmen, Jon, et al.
Published: (2012)

Cellular Restriction Factors: Exploiting the Body’s Antiviral Proteins to Combat HIV-1/AIDS
by: Kelly, Jenna N., et al.
Published: (2011)

PERSPECTIVES OF TREATMENT OF TERMINAL LIVER DISEASE IN CHRONIC HCV-INFECTION
by: E. N. German, et al.
Published: (2010-06-01)

Gene Therapy for HIV-1 Infection
by: Egerer, Lisa, et al.
Published: (2011)

Prevalence of Serological and Molecular-Biological HIV-Infection, HBV and HCV Markers among Medical Workers
by: E. V. Anufrieva, et al.
Published: (2024-12-01)

HBV, HCV, and HDV Triple-Infection—A Therapeutic Challenge
by: Alexia Anastasia Stefania Balta, et al.
Published: (2025-05-01)

Importance of Arterial Conduit Function Assessment in Chronic Congestive Heart Failure: Predictors of True Circulatory Decompensation for Optimal Timing of Mechanical Circulatory Support
by: Siniawski, Henryk, et al.
Published: (2011)

Leflunomide an Immunosuppressive Drug for Antiviral Purpose in Treatment for BK Virus-Associated Nephropathy After Kidney Transplantation
by: Bazin, Christophe
Published: (2012)

Non-invasive methods for the diagnosis of liver fibrosis in chronic HCV-infection
by: A. I. Fazul’zyanova, et al.
Published: (2021-03-01)

Oligonucleotide Applications for the Therapy and Diagnosis of Human Papillomavirus Infection
by: Benítez-Hess, María L., et al.
Published: (2012)

Surgical Pathology in HIV Infection in the Era of Antiretroviral Therapy
by: Romero-Guadarrama, Mónica Belinda
Published: (2011)